New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribose) polymerases (PARPs) are enzymes that transfer ADP-ribose groups to target proteins and thereby affect various nuclear and cytoplasmic processes. The activity of PARP family members, such as PARP1 and PARP2, is tied to cellular signalling pathways, and through poly(ADP-ribosyl)ation (PARylation) they ultimately promote changes in gene expression, RNA and protein abundance, and the location and activity of proteins that mediate signalling responses. PARPs act in a complex response network that is driven by the cellular, molecular and chemical biology of poly(ADP-ribose) (PAR). This PAR-dependent response network is crucial for a broad array of physiological and pathological responses and thus is a good target for chemical therapeutics for several diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated PARP1 will consume NAD+, generating PAR through a process called PARylation82.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [82]
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Cited by
Items 101–200 of 1,000
Molecular Pathways: How Can BRCA-Mutated Tumors Become Resistant to PARP Inhibitors?
Bouwman, P., & Jonkers, J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0225 · Cited by 158
Reversible mono‐ADP‐ribosylation of DNA breaks
Munnur, D., & Ahel, I. (2017) · The FEBS Journal · doi:10.1111/febs.14297 · Cited by 159
Cancer therapeutics: Targeting the apoptotic pathway
Khan, K. H., Blanco-Codesido, M., & Molife, L. R. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.12.012 · Cited by 180
“PARPs re key to repairing damaged DNA by modifying proteins ssociated with DNA repair [217]; PARP inhibition therefore eads to accumulation of irreparable damaged DNA triggerng the intrinsic pathway [217].”
BackgroundPARP2 mediates branched poly ADP-ribosylation in response to DNA damage
Chen, Q., Kassab, M. A., Dantzer, F., & Yu, X. (2018) · Nature Communications · doi:10.1038/s41467-018-05588-5 · Cited by 162
Reversible ADP-ribosylation of RNA
Munnur, D., Bartlett, E. J., Mikolčević, P., Kirby, I. T., Rack, J. G. M., Mikoč, A., Cohen, M. S., & Ahel, I. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz305 · Cited by 163
“PARPs are present in all eukaryotes (except yeast) and sporadically in bacteria; they regulate important cellular processes such as DNA damage repair, transcription, protein degradation, cell-cycle progression, host-virus interaction, cell division, ageing, cell death and bacterial metabolism (6–9).”
Parp-2 is required to maintain hematopoiesis following sublethal γ-irradiation in mice
Farrés, J., Martín‐Caballero, J., Martínez, C. M., Lozano, J. J., Llacuna, L., Ampurdanés, C., Ruiz‐Herguido, C., Dantzer, F., Schreiber, V., Villunger, A., et al. (2013) · Blood · doi:10.1182/blood-2012-12-472845 · Cited by 174
Protein Dynamics in Complex DNA Lesions
Aleksandrov, R., Dotchev, A., Poser, I., Krastev, D. B., Georgiev, G. S., Panova, G., Babukov, Y., Danovski, G., Dyankova-Danovska, T., Hubatsch, L., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.02.016 · Cited by 167
Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer
George, A., Kaye, S., & Banerjee, S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.191 · Cited by 158
PARP Inhibitors in Ovarian Cancer
Mittica, G., Ghisoni, E., Giannone, G., Genta, S., Aglietta, M., Sapino, A., & Valabrega, G. (2018) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892813666180305165256 · Cited by 158
Ha, K., Fiskus, W., Choi, D. S., Bhaskara, S., Cerchietti, L., Devaraj, S. G. T., Shah, B., Sharma, S., Chang, J. C., Melnick, A. M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2154 · Cited by 157
“Following this, it is catalytically activated, mediating the synthesis of PAR polymers from NAD and causing poly(ADPribosylation of itself and other proteins to recruit DDR factors involved in the DNA repair [2,10-12].”
BackgroundInfluentialPARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
Keung, M., Wu, Y., & Vadgama, J. V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040435 · Cited by 170
“A 2012 review by Gibson and Kraus highlights the complexity of PAR and PARP interaction and the necessity of PARylation to disrupt protein–protein and protein–DNA interactions [20].”
BackgroundDevelopments of CRBN-based PROTACs as potential therapeutic agents
Wang, C., Zhang, Y., Wu, Y., & Xing, D. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113749 · Cited by 162
Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation
Feijs, K. L. H., Forst, A. H., Verheugd, P., & Lüscher, B. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3601 · Cited by 154
“With respect to PAR, ALC1 is recruited to sites of DNA damag e through its macrodomain, and this is dependent on the activation of PARforming ARTDs 7, 15 .”
BackgroundMethodInfluentialBarkauskaite, E., Brassington, A., Tan, E. S., Warwicker, J., Dunstan, M. S., Piñero, B. B., Lafite, P., Ahel, M., Mitchison, T. J., Ahel, I., et al. (2013) · Nature Communications · doi:10.1038/ncomms3164 · Cited by 153
Structural Insights Into TDP-43 and Effects of Post-translational Modifications
François-Moutal, L., Perez-Miller, S., Scott, D. D., Miranda, V. G., Mollasalehi, N., & Khanna, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00301 · Cited by 151
“LLPS is important for formation of membraneless organelles, including stress granules [SGs, recently reviewed in Gomes and Shorter (2019)].”
BackgroundNew Facets in the Regulation of Gene Expression by ADP-Ribosylation and Poly(ADP-ribose) Polymerases
Ryu, K. W., Kim, D.-S., & Kraus, W. L. (2015) · Chemical Reviews · doi:10.1021/cr5004248 · Cited by 160
Self-citationEckei, L., Krieg, S., Bütepage, M., Lehmann, A., Groß, A., Lippok, B. E., Grimm, A. R., Kümmerer, B. M., Rossetti, G., Lüscher, B., et al. (2017) · Scientific Reports · doi:10.1038/srep41746 · Cited by 159
Recent advancement of piperidine moiety in treatment of cancer- A review
Goel, P., Alam, O., Naim, M. J., Nawaz, F., Iqbal, M., & Alam, I. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.017 · Cited by 150
ADP ‐ribosylation: new facets of an ancient modification
Palazzo, L., Mikoč, A., & Ahel, I. (2017) · FEBS Journal · doi:10.1111/febs.14078 · Cited by 155
“Eighteen mammalian genes with a sequence homology to PARPs/ARTDs have been described [3,7,14,16,27,28].”
BackgroundInfluentialHuang, H., Nace, G. W., McDonald, K.-A., Tai, S., Klune, J. R., Rosborough, B. R., Ding, Q., Loughran, P., Zhu, X., Beer-Stolz, D., et al. (2014) · Hepatology · doi:10.1002/hep.26976 · Cited by 146
“Poly(ADP-ribosylation) facilitates DNA repair by preventing chromatid exchange and by loosening histone wrapping.(19) However, PARP-1 overactivation leads to cell death, presumably through mechanisms linked to NAD(1) depletion.”
BackgroundKim, D.-S., Challa, S., Jones, A., & Kraus, W. L. (2020) · Genes & Development · doi:10.1101/gad.334433.119 · Cited by 160
“PARP1-mediated PARylation of HuR illustrates another aspect of RNA metabolism that is PARP regulated, namely mRNA stability.”
BackgroundInfluentialSelf-citationProcessing of protein ADP-ribosylation by Nudix hydrolases
Palazzo, L., Thomas, B., Jemth, A.-S., Colby, T., Leidecker, O., Feijs, K. L. H., Zaja, R., Loseva, O., Puigvert, J. C., Matic, I., et al. (2015) · Biochemical Journal · doi:10.1042/bj20141554 · Cited by 138
Rapid Detection and Signaling of DNA Damage by PARP-1
Pandey, N., & Black, B. E. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.01.014 · Cited by 151
House dust mite–induced asthma causes oxidative damage and DNA double-strand breaks in the lungs
Chan, T. K., Loh, X. Y., Peh, H. Y., Tan, W. N. F., Tan, W. S. D., Li, N., Tay, I. J. J., Wong, W. S. F., & Engelward, B. P. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.02.017 · Cited by 152
Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy
Mistry, I. N., Thomas, M., Calder, E. D. D., Conway, S. J., & Hammond, E. M. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.03.024 · Cited by 154
Metabolic Signaling to Chromatin
Berger, S. L., & Sassone-Corsi, P. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019463 · Cited by 139
Regulation of Wnt/β‐catenin signalling by tankyrase‐dependent poly(ADP‐ribosyl)ation and scaffolding
Mariotti, L., Pollock, K., & Guettler, S. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14038 · Cited by 144
“…(TNKS and TNKS2; Tnks and Tnks2 in other species discussed; from here on simply referred to as ‘tankyrase’where concepts apply to both tankyrases), is a PARP, and as such catalyses the attachment of PAR chains onto its substrates (see Gibson and Kraus, 2012; and Haikarainen et al., 2014a).”
BackgroundBrighty, G. J., Botham, R. C., Li, S., Nelson, L. T., Mortenson, D. E., Li, G., Morisseau, C. H. P., Wang, H., Hammock, B. D., Sharpless, K. B., et al. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0530-4 · Cited by 148
Proteasome Regulation by ADP-Ribosylation
Cho-Park, P. F., & Steller, H. (2013) · Cell · doi:10.1016/j.cell.2013.03.040 · Cited by 138
Nonapoptotic cell death in acute kidney injury and transplantation
Linkermann, A. (2016) · Kidney International · doi:10.1016/j.kint.2015.10.008 · Cited by 145
PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
Ding, L., Chen, X., Xu, X., Qian, Y., Liang, G., Yao, F., Yao, Z., Wu, H., Zhang, J., He, Q., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0071 · Cited by 147
The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
Li, S., Wang, L., Wang, Y., Zhang, C., Hong, Z., & Han, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01360-x · Cited by 150
“The 17 members of PARP family share a conserved catalytic domain and only these 3 DNA-dependent PARP members possess Trp-Gly-Arg (WGR) domain which is responsible for DNA interaction in DNA damage response pathway [9].”
BackgroundCambronne, X. A., & Kraus, W. L. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.05.010 · Cited by 137
Self-citationSelective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Houl, J. H., Ye, Z., Brosey, C. A., Balapiti-Modarage, L. P. F., Namjoshi, S., Bacolla, A., Laverty, D. J., Walker, B. L., Pourfarjam, Y., Warden, L. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13508-4 · Cited by 145
PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response
Kim, C., Wang, X.-D., & Yu, Y. (2020) · eLife · doi:10.7554/elife.60637 · Cited by 136
van Beek, L., McClay, É., Patel, S., Schimpl, M., Spagnolo, L., & de Oliveira, T. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105112 · Cited by 143
“paired DNA bases of the SSB onto 4DQY, as previously de i d [1].”
BackgroundMethodThe Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency
Gatti, M., Imhof, R., Huang, Q. D., Baudis, M., & Altmeyer, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107985 · Cited by 145
“Poly(ADP-ribose) polymerase 1 (PARP1) is an abundant chromatin-associated enzyme, whose activity is strongly induced in response to genotoxic stress (Gibson and Kraus, 2012; Ray Chaudhuri and Nussenzweig, 2017; Teloni and Altmeyer, 2016).”
BackgroundTimeless Interacts with PARP-1 to Promote Homologous Recombination Repair
Xie, S., Mortusewicz, O., Ma, H. T., Herr, P., Poon, R. Y. C., Helleday, T., & Qian, C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.031 · Cited by 145
PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation
Min, A., & Im, S. (2020) · Cancers · doi:10.3390/cancers12020394 · Cited by 148
“There are DNA damage responses (DDRs), the sophisticated mechanisms of genome protection in cells, that function to activate the cell cycle checkpoint pathway to maintain genome stability by stopping or delaying the cell cycle during DNA damage or unstable DNA replication to allow the repair of damaged DNA lesions.”
BackgroundInfluentialChromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Feng, F. Y., de Bono, J. S., Rubin, M. A., & Knudsen, K. E. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.016 · Cited by 132
“elsewhere (Golia et al., 2015; Li and Yu, 2014); briefly, PARP1 binds to double-stranded DNA breaks within milliseconds of the damage event, induces PARylation, and attracts the MRN”
Welsby, I., Hutin, D., Gueydan, C., Kruys, V., Rongvaux, A., & Léo, O. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589515 · Cited by 140
“In addition to these diversified catalytic properties, members of the PARP superfamily are multi-modular proteins possessing a wide variety of domains including zinc fingers, breast cancer-1 protein (BRCA1) C terminus-like (BRCT) motifs, ankyrin repeats, macro domains, and WWE domains, compatible with their role in a…”
BackgroundRecognition of Mono-ADP-Ribosylated ARTD10 Substrates by ARTD8 Macrodomains
Forst, A. H., Karlberg, T., Herzog, N., Thorsell, A. G., Groß, A., Feijs, K. L. H., Verheugd, P., Kursula, P., Nijmeijer, B., Kremmer, E., et al. (2013) · Structure · doi:10.1016/j.str.2012.12.019 · Cited by 134
“Moreover, and as discussed above, macrodomains are interaction modules of PAR (Gibson and Kraus, 2012).”
BackgroundThe recognition and removal of cellular poly(ADP‐ribose) signals
Barkauskaite, E., Jankevicius, G., Ladurner, A. G., Ahel, I., & Timinszky, G. (2013) · The FEBS Journal · doi:10.1111/febs.12358 · Cited by 123
Min, W., Bruhn, C., Grigaravičius, P., Zhou, Z., Li, F., Krüger, A., Siddeek, B., Greulich, K., Popp, O., Meisezahl, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3993 · Cited by 142
Zarkovic, G., Belousova, E. A., Talhaoui, I., Saint-Pierre, C., Kutuzov, M. M., Matkarimov, B. T., Biard, D., Gasparutto, D., Lavrik, O. I., & Ishchenko, A. A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1318 · Cited by 124
The Role of PARPs in Inflammation—And Metabolic—Related Diseases: Molecular Mechanisms and Beyond
Ke, Y., Wang, C., Zhang, J., Zhong, X., Wang, R., Zeng, X., & Ba, X. (2019) · Cells · doi:10.3390/cells8091047 · Cited by 121
“Activated PARP1 accounts for 85%-90% of the total PARP activity in cells, and PARP1 is the most extensively and intensively studied member of the PARP family [3,14,25].”
BackgroundSmith, M. A., Reynolds, C. P., Kang, M. H., Kolb, E. A., Gorlick, R., Carol, H., Lock, R. B., Keir, S. T., Maris, J. M., Billups, C. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2572 · Cited by 121
“PARP1 plays a central role in the recognition of single-strand DNA damage and is involved in chromatin modification, transcription, and DNA repair (1).”
ARTD10 substrate identification on protein microarrays: regulation of GSK3β by mono-ADP-ribosylation
Feijs, K. L., Kleine, H., Braczynski, A., Forst, A. H., Herzog, N., Verheugd, P., Linzen, U., Kremmer, E., & Lüscher, B. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-5 · Cited by 121
“Poly-ADP-ribosylation by ARTD1 (formerly PARP1) has been investigated most thoroughly and is best known for its role in DNA damage repair and the control of chromatin and gene transcription [4-6].”
BackgroundYAMAGUCHI, H., Du, Y., Nakai, K., Ding, M., Chang, S. H., Hsu, J. L., Yao, J., Wei, Y., Nie, L., Jiao, S., et al. (2017) · Oncogene · doi:10.1038/onc.2017.311 · Cited by 129
Li, L., Zhao, H. J., Liu, P., Li, C., Quanquin, N. M., Ji, X., Sun, N., Du, P., Qin, C., Lü, N., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aas9332 · Cited by 124
“Because the Gly565 within the PARP domain of human PARP12 binds the amide group of NAD+, which is essential for mono-ADPribosylation (MAR) activity (32, 39), we mutated PARP12 at that site (PARP12 G565A) to impair its PARP enzyme activity (Fig.”
BackgroundInhibitors of PARP: Number crunching and structure gazing
Rudolph, J., Jung, K., & Luger, K. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121979119 · Cited by 125
Genome instability in Alzheimer disease
Hou, Y., Song, H., Croteau, D. L., Akbari, M., & Bohr, V. A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.04.005 · Cited by 120
“PARP1 is involved in the regulation of numerous cellular processes, including multiple DNA repair pathways (Burkle, 2006; Gibson and Kraus, 2012).”
BackgroundTargeted NUDT5 inhibitors block hormone signaling in breast cancer cells
Page, B. D. G., Valerie, N. C. K., Wright, R. H. G., Wallner, O. A., Isaksson, R., Carter, M., Rudd, S. G., Loseva, O., Jemth, A., Almlöf, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02293-7 · Cited by 129
MORC2 regulates DNA damage response through a PARP1-dependent pathway
Zhang, L., & Li, D. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz545 · Cited by 124
“Second, PAR serves as a chromatin-based platform for the recruitment of DNA repair factors possessing specific PAR-interacting motifs to sites of DNA lesions via non-covalent interactions, facilitating chromatin remodeling and DNA repair (15,17).”
BackgroundInfluentialADP-ribosylation of DNA and RNA
Groslambert, J., Prokhorova, E. A., & Ahel, I. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103144 · Cited by 124
“Of note, because of their critical role in the DDR, PARP1 and PARP2 have emerged as important anticancer drug targets, with several PARP inhibitors now used against breast, ovarian, pancreatic and prostate cancers in the clinic [34,35].”
InfluentialPatching Broken DNA: Nucleosome Dynamics and the Repair of DNA Breaks
Gursoy-Yuzugullu, O., House, N., & Price, B. D. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.11.021 · Cited by 112
The Genetic Architecture of Multiple Myeloma
Prideaux, S. M., O’Brien, E. C., & Chevassut, T. J. T. (2014) · Advances in Hematology · doi:10.1155/2014/864058 · Cited by 127
De Lorenzo, S. B., Patel, A. G., Hurley, R. M., & Kaufmann, S. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00228 · Cited by 111
MacroH2A1.1 and PARP-1 cooperate to regulate transcription by promoting CBP-mediated H2B acetylation
Chen, H., Ruiz, P. D., Novikov, L., Casill, A. D., Park, J. W., & Gamble, M. J. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2903 · Cited by 120
PARP Trapping Beyond Homologous Recombination and Platinum Sensitivity in Cancers
Murai, J., & Pommier, Y. G. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055914 · Cited by 119
“In turn, PARP activation recruits the BER scaffolding protein XRCC1 with polymerase β (POLB) and ligase III.”
BackgroundInfluentialMultivalent Microtubule Recognition by Tubulin Tyrosine Ligase-like Family Glutamylases
Garnham, C. P., Vemu, A., Wilson-Kubalek, E. M., Yu, I., Szyk, A., Lander, G. C., Milligan, R. A., & Roll-Mecak, A. (2015) · Cell · doi:10.1016/j.cell.2015.04.003 · Cited by 115
“Those enzymes use common catalytic residues to both initiate and then elongate ADP ribose chains of varying lengths and branching structures (Gibson and Kraus, 2012).”
Hocsak, E., Szabo, V., Kalman, N., Antus, C., Cseh, A., Sumegi, K., Eros, K., Hegedus, Z., Gallyas, F., Sumegi, B., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.018 · Cited by 109
“dependent DNA damage sensor that binds to both single- and double stranded DNA breaks [1,2] facilitating both base excision repair and homologous recombination [3,4].”
BackgroundNuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis
McGurk, L., Mojsilovic-Petrovic, J., Van Deerlin, V. M., Shorter, J., Kalb, R. G., Lee, V. M., Trojanowski, J. Q., Lee, E. B., & Bonini, N. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0586-1 · Cited by 114
“PARPs are enzymes that catabolize NAD to sequentially add ADP-ribose subunits onto target proteins, generating polymers of poly(ADP-ribose) (PAR) [37].”
BackgroundGeneration and Characterization of Recombinant Antibody-like ADP-Ribose Binding Proteins
Gibson, B. A., Conrad, L. B., Huang, D., & Kraus, W. L. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00670 · Cited by 114
Self-citationPoly(ADP-ribose): A signaling molecule in different paradigms of cell death
Aredia, F., & Scovassi, A. I. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.021 · Cited by 124
“ADP-ribose from NAD, releasing nicotinamide and protons [2,3].”
BackgroundADP-ribosylation signalling and human disease
Palazzo, L., Mikolčević, P., Mikoč, A., & Ahel, I. (2019) · Open Biology · doi:10.1098/rsob.190041 · Cited by 121
“Seventeen members of the ARTD superfamily have been identified in mammals and are known as poly(ADP-ribose) polymerases (PARPs) [3,41,53].”
BackgroundThe taming of PARP1 and its impact on NAD+ metabolism
Hurtado-Bagès, S., Knobloch, G., Ladurner, A. G., & Buschbeck, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.014 · Cited by 130
Luo, X., Ryu, K. W., Kim, D.-S., Nandu, T. S., Medina, C. J., Gupte, R., Gibson, B. A., Soccio, R. E., Yu, Y., Gupta, R. K., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.11.015 · Cited by 116
“…polymerase-1 (PARP-1) (also known as ARTD1) is an abundant nuclear protein involved in a variety of nuclear processes, including transcription, RNA processing, and 260 Molecular Cell 65, 260–271, January 19, 2017 ª 2016 Elsevier In DNA repair (Gibson and Kraus, 2012; Ryu et al., 2015).”
BackgroundSelf-citationNicolae, C. M., Aho, E. R., Vlahos, A. H. S., Choe, K. N., De, S., Karras, G. I., & Moldovan, G.-L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556340 · Cited by 106
“The poly(ADPribose) polymerase PARP1 is important for activation of the DNA damage response and promotes recruitment of repair enzymes to chromatin (23, 25, 49, 50).”
BackgroundTargeting DNA repair in cancer: current state and novel approaches
Klinakis, A., Karagiannis, D., & Rampias, T. N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03299-8 · Cited by 114
“The PAR chains form a platform to recruit DNA repair proteins via their PAR-binding domains at the sites of DNA damage [20, 21].”
BackgroundResistance to PARP-Inhibitors in Cancer Therapy
Montoni, A., Robu, M., Pouliot, É., & Shah, G. M. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00018 · Cited by 102
“Among three such PARPs, PARP-1 is the principle responder to DNA damage, as it rapidly reaches the damaged site and mounts a robust catalytic activation response that influences different cellular responses to DNA damage (Javle and Curtin, 2011; Yélamos et al., 2011; Gibson and Kraus, 2012).”
BackgroundNicotinamide and WLDS Act Together to Prevent Neurodegeneration in Glaucoma
Williams, P. A., Harder, J. M., Foxworth, N. E., Cardozo, B. H., Cochran, K. E., & John, S. W. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00232 · Cited by 108
“NAM may also protect by modulating DNA damage responses and/or vascular tone, due to its direct inhibitory effects on PARP and cyclic ADP ribose (Sethi et al., 1996; Geiger et al., 2000; Gibson and Kraus, 2012).”
RNA Regulation by Poly(ADP-Ribose) Polymerases
Bock, F. J., Todorova, T. T., & Chang, P. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.037 · Cited by 100
“Targets proteins are either mono(ADP-ribosyl)ated or modified with long polymers of poly(ADP-ribose) that play additional regulatory functions by binding and recruiting proteins through non-covalent interactions (Bürkle, 2005; Gibson and Kraus, 2012; Vyas et al., 2014).”
BackgroundTiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis
Zhang, L., Cao, J., Dong, L., & Lin, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921815117 · Cited by 119
“A is a reversible protein posttranslational modification (PTM) that modifies substrate proteins with a single or multiple ADP-ribosyl groups (1).”
Kluth, M., Harasimowicz, S., Burkhardt, L., Grupp, K., Krohn, A., Prien, K., Gjoni, J., Haß, T., Galal, R., Graefen, M., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28784 · Cited by 104
PARP2 Is the Predominant Poly(ADP-Ribose) Polymerase in Arabidopsis DNA Damage and Immune Responses
Song, J., Keppler, B. D., Wise, R. R., & Bent, A. F. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005200 · Cited by 107
“Poly(ADP-ribosyl)ation is a post-translational modification mediated by poly(ADP-ribose) polymerase (PARP) enzymes, in which negatively charged ADP-ribose units are transferred from donor nicotinamide adenine dinucleotide (NAD) molecules onto target proteins [7].”
BackgroundInfluentialUncoupling of PARP1 trapping and inhibition using selective PARP1 degradation
Wang, S., Han, L., Han, J., Li, P., Ding, Q., Zhang, Q.-J., Liu, Z.-P., Chen, C., & Yu, Y. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0379-2 · Cited by 107
Riccio, A. A., Cingolani, G., & Pascal, J. M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1376 · Cited by 105
“The poly(ADP-ribose) polymerase (PARP) family of enzymes is composed of 17 members that regulate multiple aspects of cell biology (1,2).”
BackgroundGlaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
Williams, P. A., Harder, J. M., & John, S. W. M. (2017) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000767 · Cited by 102
Serine-linked PARP1 auto-modification controls PARP inhibitor response
Prokhorova, E. A., Zobel, F., Smith, R., Zentout, S., Gibbs‐Seymour, I., Schützenhofer, K., Peters, A., Groslambert, J., Zorzini, V., Agnew, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24361-9 · Cited by 105
Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins
Nelson, D. E., Randle, S. J., & Laman, H. (2013) · Open Biology · doi:10.1098/rsob.130131 · Cited by 116
“It has been postulated that this mechanism might tie proteasome activity to cellular metabolism as NADþ is used for ADP-ribosylation of PI31 [111,112].”
BackgroundPoly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response
Tallis, M., Morra, R., Barkauskaite, E., & Ahel, I. (2013) · Chromosoma · doi:10.1007/s00412-013-0442-9 · Cited by 116
“PARPs 9 and 13), ADP-ribosylation activity has not yet been reported (Gibson and Kraus 2012; Otto et al. 2005).”
BackgroundInfluentialTET-mediated oxidation of methylcytosine causes TDG or NEIL glycosylase dependent gene reactivation
Müller, U., Bauer, C., Siegl, M., Rottach, A., & Leonhardt, H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku552 · Cited by 100
“Furthermore, interactions of all three TET proteins were observed with PARP1, which detects single-strand breaks and modifies repair factors by PolyADP-ribosylation (61).”
BackgroundThe role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
Li, M., & Yu, X. (2014) · Oncogene · doi:10.1038/onc.2014.295 · Cited by 101
Guo, T., Zuo, Y., Qian, L., Liu, J., Yuan, Y., Xu, K., Miao, Y., Feng, Q., Chen, X., Jin, L., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0428-3 · Cited by 102
Full-length GSDME mediates pyroptosis independent from cleavage
Zhou, B., Jiang, Z., Dai, M.-R., Ai, Y.-L., Li, X., Zhong, C., Wu, L.-Z., Chen, Q.-T., Chen, H., & Wu, Q. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01463-2 · Cited by 104
“PARP5a and PARP5b have been reported to function as enzymes that catalyse PARylation on their respective substrates 32 .”
Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases
Mashimo, M., Kato, J., & Moss, J. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.03.005 · Cited by 107
Alternative Modes of Binding of Poly(ADP-ribose) Polymerase 1 to Free DNA and Nucleosomes
Clark, N., Kramer, M., Muthurajan, U. M., & Luger, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397067 · Cited by 107
Odon, V., Fros, J. J., Goonawardane, N., Dietrich, I., Ibrahim, A., Alshaikhahmed, K., Nguyen, D. V., & Simmonds, P. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz581 · Cited by 103
“The processes by which viruses adapt to and co-exist with their hosts over long periods clearly provide them with the opportunity to finesse numerous aspects of the mononucleotide and dinucleotide composition to maximize fitness (70) ZAP is a member of a larger family of poly-adenosine diphosphate ribosyl transferase…”
BackgroundIntracellular Mono-ADP-Ribosylation in Signaling and Disease
Bütepage, M., Eckei, L., Verheugd, P., & Lüscher, B. (2015) · Cells · doi:10.3390/cells4040569 · Cited by 100
Liu, L., Kong, M., Gassman, N. R., Freudenthal, B. D., Prasad, R., Zhen, S., Watkins, S. C., Wilson, S. H., & Van Houten, B. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1047 · Cited by 93
“Although the primary target of PARP1 is itself (7), many proteins, including DNA processing enzymes, have been shown to either be modified by PARP1 or bind to PAR (8,9).”
BackgroundTargeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule
Elhassan, Y., Philp, A., & Lavery, G. G. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00092 · Cited by 101
Structural insights into ADP-ribosylation of ubiquitin by Deltex family E3 ubiquitin ligases
Chatrin, C., Gabrielsen, M., Buetow, L., Nakasone, M. A., Ahmed, S. F., Sumpton, D., Sibbet, G. J., Smith, B. O., & Huang, D. T. (2020) · Science Advances · doi:10.1126/sciadv.abc0418 · Cited by 94
“ADP-ribose can be transferred to side chains with a nucleophilic nitrogen, oxygen, or sulfur atom to generate an N-, O-, or S-glycosidic linkage, respectively (10, 11).”
BackgroundPoly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases
Thapa, K., Khan, H., Sharma, U., Grewal, A. K., & Singh, T. G. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118975 · Cited by 92
Mapping PARP-1 Auto-ADP-ribosylation Sites by Liquid Chromatography–Tandem Mass Spectrometry
Chapman, J. D., Gagné, J.-P., Poirier, G. G., & Goodlett, D. R. (2013) · Journal of Proteome Research · doi:10.1021/pr301219h · Cited by 85
The BRCT domain of PARP1 binds intact DNA and mediates intrastrand transfer
Rudolph, J., Muthurajan, U. M., Palacio, M., Mahadevan, J., Roberts, G., Erbse, A. H., Dyer, P. N., & Luger, K. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.11.014 · Cited by 95
Karicheva, O., Rodríguez-Vargas, J. M., Wadier, N., Martin-Hernandez, K., Vauchelles, R., Magroun, N., Tissier, A., Schreiber, V., & Dantzer, F. (2016) · Oncotarget · doi:10.18632/oncotarget.11627 · Cited by 97
“PARP1, the founding member of the PARP family (17 members), synthesizes polymers of ADP-ribose onto target proteins using NAD+ as a substrate [24, 25].”
Fu, L., Wang, S., Wang, X., Wang, P., Zheng, Y., Yao, D., Guo, M., Zhang, L., & Ouyang, L. (2016) · Scientific Reports · doi:10.1038/s41598-016-0007-2 · Cited by 91
Chandramouly, G., McDevitt, S., Sullivan, K., Kent, T., Luz, A. N., Glickman, J. F., Andrake, M., Skórski, T., & Pomerantz, R. T. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.10.003 · Cited by 92
“…chromatin, and cellular stress response, in addition to DNA repair, its inhibition inevitably causes a large number of shortterm, and possibly long-term, side effects in normal cells (Farmer et al., 2005; Gibson and Kraus, 2012; Ji and Tulin, 2010; Lord and Ashworth, 2012; Thomas and Tulin, 2013).”
Szántó, M., & Bai, P. (2020) · Genes & Development · doi:10.1101/gad.334284.119 · Cited by 97
“Although all PARPs inherited the family name of the foundingmember, PARP-1, the PARP “polyenzymes” include only PARP-1, PARP-2, and the tankyrases (PARP5a and PARP-5b) (Gibson and Kraus 2012).”
Background
Metadata
- Authors
- Gibson, B. A., & Kraus, W. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Kraus, W. Lee
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-06-20
- Volume
- 13
- Issue
- 7
- Pages
- 411-424
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1965006127
- Cited by
- 1,226
- References
- 128
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 76 · 2023: 84 · 2022: 94 · 2021: 113 · 2020: 108 · 2019: 83 · 2018: 97 · 2017: 94 · 2016: 86 · 2015: 91 · 2014: 77 · 2013: 79 · 2012: 7
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- poly(ADP-ribosyl)ation, poly(ADP-ribose), PARP1, PARP2, PARP family, protein modification, signal transduction, gene expression regulation, PARP inhibitors
- MeSH terms
- Animals, Catalysis, Cell Nucleus, Cherubism, Cytoplasm, Gene Expression Regulation, Humans, Models, Molecular, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Polymers, Protein Conformation, Protein Processing, Post-Translational, RNA, Signal Transduction, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.